Building upon leading technologies
“CytoReason has strengthened its platforms using NVIDIA’s latest accelerated computing and AI platforms, achieving more than 10x acceleration for inference workloads. Our continued collaboration with CytoReason will help enable more life sciences companies to benefit from CytoReason’s predictive clinical insights.”
Every piece of the platform contributes to better disease biology evidence
No single algorithm gives the complete picture. Different data requires different modeling approaches. CytoReason combines multiple differentiated capabilities into a scientific evidence generation platform that continuously improves over time.
{{ cap.title }}
Customer data becomes part of the model- not just another dataset
Customers can securely integrate their proprietary data into CytoReason's disease models, creating an enhanced model exclusive to their organization. The model combines insights from the customer's proprietary data with biological learning accumulated through summary statistics across datasets - revealing biological connections that the customer's data alone could not uncover.
Evidence delivered the way your teams work
Different organizations consume disease biology evidence differently. CytoReason delivers evidence through the experience that best fits your scientific workflow.
Your (clinical) scientists and computational biologists generate and explore disease biology evidence directly in CytoReason's platform, with visibility across projects, programs and the portfolio. Enabled by LINA Agent through agentic layer and integrated into your environment.
Your team generates and explores the evidence.
Work alongside CytoReason's scientific services team on CytoReason's platform to answer your organization's high-priority portfolio and biological questions.
Your team works with CytoReason to generate and explore the evidence.
Receive decision-ready disease biology evidence addressing specific portfolio and biological questions, delivered by CytoReason as a clear, explainable scientific report.
For companies with limited asset portfolio, CytoReason delivers the evidence to your team.
Scientifically validated.
Industry proven.
Our computational methods are scientifically validated and published. The disease biology evidence they generate is further validated by customers -independently and in collaboration with CytoReason -across real-world R&D programs.